首页> 外文OA文献 >Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis

【2h】

Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis

机译：甲状腺癌酪氨酸激酶抑制剂对甲状腺癌的比较疗效和安全性：系统综述和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takaaki Oba; Tatsunori Chino; Ai Soma; Tadafumi Shimizu; Mayu Ono; Tokiko Ito; Toshiharu Kanai; Kazuma Maeno; Ken-ichi Ito;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis [J] . Takaaki Oba, Tatsunori Chino, Ai Soma, Endocrine journal . 2020,第12期

机译：甲状腺癌酪氨酸激酶抑制剂对甲状腺癌的比较疗效和安全性：系统评价和荟萃分析
2. Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials [J] . FunakoshiT., LatifA., GalskyM.D. Cancer Treatment Reviews . 2014,第5期

机译：在实体癌的细胞毒性化学疗法中添加VEGFR和EGFR家族的口服小分子酪氨酸激酶抑制剂的安全性和有效性：随机对照试验的系统评价和荟萃分析
3. Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis [J] . Fachi Mariana M., Tonin Fernanda S., Leonart Leticia P., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：慢性髓性白血病酪氨酸激酶抑制剂的比较疗效和安全性：系统综述与网络荟萃分析
4. Selective tyrosine kinase inhibitor, STI571, inhibitsgrowth of p53 mutant anaplastic thyroid cancer cellsby inducing S-G2 transition arrest [C] . Alexei P. Podtcheko, Satoshi Tsuda, Akira Ohtsuru International Consortium for Medical Care of Hibakusha and Radiation Life Science . 2003

机译：选择性酪氨酸激酶抑制剂，STI571，P53突变体的抑制性诱导S-G2过渡逮捕的抑制性甲状腺癌细胞
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials [O] . Wufuer Yimaer, Aizizi Abudouyimu, Ye Tian, 2016

机译：血管内皮生长因子受体酪氨酸激酶抑制剂治疗晚期甲状腺癌的有效性和安全性：一项随机对照试验的荟萃分析
7. Comparison of the Efficacy and Safety of EFGR Tyrosine Kinase Inhibitor Monotherapy with Standard Second-line Chemotherapy in Previously Treated Advanced Non-small-cell Lung Cancer: a Systematic Review and Meta-analysis [O] . Wei-Xiang Qi, Zan Shen, Feng Lin, 2012

机译：EFGR酪氨酸激酶抑制剂单疗法与预先治疗的非小细胞肺癌标准二线化疗的疗效和安全性比较：系统综述和荟萃分析
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis

著录项

引文网络

相似文献

相关主题

期刊订阅